Skip to Main Content

Paper Details

Therapies for rare diseases: therapeutic modalities, progress and challenges ahead.
Nat Rev Drug Discov
155
2020
digital, patients, rare disease, rare diseases
Author NameAffiliation
Christopher P AustinNational Center for Advancing Translational Sciences, National Institutes of Health
Stephen C GroftNational Center for Advancing Translational Sciences, National Institutes of Health
Tudor I OpreaUniversity of New Mexico Albuquerque
Tudor I OpreaUNM Comprehensive Cancer Center, University of New Mexico Health Science Center
Tudor I OpreaUniversity of New Mexico Albuquerque
Tudor I OpreaUNM Comprehensive Cancer Center, University of New Mexico Health Science Center
  • 1 - 6

Datasets

Release 1.2